Contract 75D30123D16647
Moderna Us, Inc. · Department Of Health And Human Services · June 14, 2023
Moderna Us, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on June 14, 2023 for $160.86 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 10 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 9, 2025. If all options are exercised, the contract could reach $601.37 million.
Contract details
- PIID
- 75D30123D16647
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- June 14, 2023
- Latest action
- July 9, 2025
Description
PEDIATRIC COVID-19 VACCINES
Modification timeline
-
July 9, 2025Mod P00010$0
-
January 15, 2025Mod P00009$-148.66M
-
July 11, 2024Mod P00008$0
-
June 3, 2024Mod P00007$0
-
May 2, 2024Mod P00006$0
-
September 12, 2023Mod P00005$0
-
September 5, 2023Mod P00004$0
-
September 5, 2023Mod P00003$0
-
August 29, 2023Mod P00002$309.51M
-
August 24, 2023Mod P00001$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30123D16647?
Contract 75D30123D16647 is a federal contract awarded to Moderna Us, Inc. by Department Of Health And Human Services on June 14, 2023 for $160.86 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 10 times since the base award.
Who won contract 75D30123D16647?
Moderna Us, Inc. won contract 75D30123D16647 from Department Of Health And Human Services.
How much is contract 75D30123D16647 worth?
Contract 75D30123D16647 has obligated $160.86 million to date, with a total potential value of $601.37 million if all options are exercised.